Impact of AMP-activated protein kinase a1 deficiency on tissue injury following unilateral ureteral obstruction

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Mia, Sobuj ^a   Federico, Giuseppina ^b   Feger, Martina ^a   Pakladok, Tatsiana ^a   Meissner, Adrian ^a   Voelkl, Jakob ^a   Groene, Hermann Josef ^b   Alesutan, Ioana ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; AMP ACTIVATED PROTEIN KINASE ALPHA1; CELL MARKER; COLLAGEN TYPE 1; CXCL16 CHEMOKINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INTERLEUKIN 6; PROTEIN C FOS; PROTEIN CD206; PROTEIN PAI1; PROTEIN SNAI1; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; UNCLASSIFIED DRUG; AMPK ALPHA1 SUBUNIT, MOUSE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; KIDNEY FIBROSIS; KIDNEY TUBULE DAMAGE; MOUSE; MYOFIBROBLAST; NONHUMAN; PROTEIN EXPRESSION; TISSUE INJURY; UNILATERAL URETERAL OBSTRUCTION; UPREGULATION; URETER OBSTRUCTION; ANIMAL; CELL CULTURE; COMPLICATION; ENZYME IMMUNOASSAY; FIBROSIS; GENETICS; KIDNEY DISEASES; KNOCKOUT MOUSE; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; FIBROSIS; IMMUNOENZYME TECHNIQUES; KIDNEY DISEASES; MICE; MICE, KNOCKOUT; MYOFIBROBLASTS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; URETERAL OBSTRUCTION;

EID: 84942599563     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135235     Document Type: Article

References (63)

1. Chevalier RL, Forbes MS, Thornhill BA. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int. 2009; 75(11): 1145-52. doi:10.1038/ki.2009.86 PMID: 19340094.
2. He J, Xu Y, Koya D, Kanasaki K. Role of the endothelial-To-mesenchymal transition in renal fibrosis of chronic kidney disease. Clin Exp Nephrol. 2013; 17(4): 488-97. doi:10.1007/s10157-013-0781-0 PMID: 23430391.
3. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int. 2006; 69(2): 213-7. doi:10.1038/sj.ki.5000054 PMID: 16408108.
4. Grgic I, Duffield JS, Humphreys BD. The origin of interstitial myofibroblasts in chronic kidney disease. Pediatr Nephrol. 2012; 27(2): 183-93. doi:10.1007/s00467-011-1772-6 PMID: 21311912; PubMed Central PMCID: PMC3116994.
5. Kriz W, Kaissling B, Le Hir M. Epithelial-mesenchymal transition(EMT) in kidney fibrosis: fact or fantasy? J Clin Invest. 2011; 121(2): 468-74. PMID: 21370523; PubMed Central PMCID: PMC3026733.
6. Liu Y. New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol. 2010; 21(2): 212-22. doi:10.1681/ASN.2008121226 PMID: 20019167.
7. Cheng J, Truong LD, Wu X, Kuhl D, Lang F, Du J. Serum-And glucocorticoid-regulated kinase 1 is upregulated following unilateral ureteral obstruction causing epithelial-mesenchymal transition. Kidney Int. 2010; 78(7): 668-78. doi:10.1038/ki.2010.214 PMID: 20631674; PubMed Central PMCID: PMC3935313.
8. Wynn TA. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest. 2007; 117(3): 524-9. doi:10.1172/JCI31487 PMID: 17332879; PubMed Central PMCID: PMC1804380.
9. Yanagita M. Inhibitors/antagonists of TGF-beta system in kidney fibrosis. Nephrol Dial Transplant. 2012; 27(10): 3686-91. doi:10.1093/ndt/gfs381 PMID: 23114895.
10. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003; 425(6958): 577-84. doi:10.1038/nature02006 PMID: 14534577.
11. Bottinger EP, Bitzer M. TGF-beta signaling in renal disease. J Am Soc Nephrol. 2002; 13(10): 2600-10. PMID: 12239251.
12. Choi ME, Ding Y, Kim SI. TGF-beta signaling via TAK1 pathway: role in kidney fibrosis. Semin Nephrol. 2012; 32(3): 244-52. doi:10.1016/j.semnephrol.2012.04.003 PMID: 22835455; PubMed Central PMCID: PMC3407377.
13. Chen Z, Shen X, Shen F, Zhong W, Wu H, Liu S, et al. TAK1 activates AMPK-dependent cell death pathway in hydrogen peroxide-Treated cardiomyocytes, inhibited by heat shock protein-70. Mol Cell Biochem. 2013; 377(1-2): 35-44. doi:10.1007/s11010-013-1568-z PMID: 23378049.
14. Kim SY, Jeong S, Jung E, Baik KH, Chang MH, Kim SA, et al. AMP-Activated protein kinase-Alpha1 as an activating kinase of TGF-beta-Activated kinase 1 has a key role in inflammatory signals. Cell Death Dis. 2012; 3: e357. doi:10.1038/cddis.2012.95 PMID: 22833096; PubMed Central PMCID: PMC3406594.
15. Strippoli R, Benedicto I, Perez Lozano ML, Pellinen T, Sandoval P, Lopez-Cabrera M, et al. Inhibition of transforming growth factor-Activated kinase 1(TAK1) blocks and reverses epithelial to mesenchymal transition of mesothelial cells. PLoS One. 2012; 7(2): e31492. doi:10.1371/journal.pone.0031492 PMID: 22384029; PubMed Central PMCID: PMC3288041.
16. Guo F, Hutchenreuther J, Carter DE, Leask A. TAK1 is required for dermal wound healing and homeostasis. J Invest Dermatol. 2013; 133(6): 1646-54. doi:10.1038/jid.2013.28 PMID: 23340735.
17. Zaha VG, Young LH. AMP-Activated protein kinase regulation and biological actions in the heart. Circ Res. 2012; 111(6): 800-14. doi:10.1161/CIRCRESAHA.111.255505 PMID: 22935535.
18. Viollet B, Horman S, Leclerc J, Lantier L, Foretz M, Billaud M, et al. AMPK inhibition in health and disease. Crit Rev Biochem Mol Biol. 2010; 45(4): 276-95. doi:10.3109/10409238.2010.488215 PMID: 20522000; PubMed Central PMCID: PMC3132561.
19. Gusarova GA, Dada LA, Kelly AM, Brodie C, Witters LA, Chandel NS, et al. Alpha1-AMP-Activated protein kinase regulates hypoxia-induced Na,K-ATPase endocytosis via direct phosphorylation of protein kinase C zeta. Mol Cell Biol. 2009; 29(13): 3455-64. doi:10.1128/MCB.00054-09 PMID: 19380482; PubMed Central PMCID: PMC2698765.
20. Qin S, De Vries GW. alpha2 But not alpha1 AMP-Activated protein kinase mediates oxidative stressinduced inhibition of retinal pigment epithelium cell phagocytosis of photoreceptor outer segments. J Biol Chem. 2008; 283(11): 6744-51. doi:10.1074/jbc.M708848200 PMID: 18195011.
21. Towler MC, Hardie DG. AMP-Activated protein kinase in metabolic control and insulin signaling. CircRes. 2007; 100(3): 328-41.
22. Winder WW, Thomson DM. Cellular energy sensing and signaling by AMP-Activated protein kinase. Cell Biochem Biophys. 2007; 47(3): 332-47. PMID: 17652779
23. Evans AM, Mustard KJ, Wyatt CN, Peers C, Dipp M, Kumar P, et al. Does AMP-Activated protein kinase couple inhibition of mitochondrial oxidative phosphorylation by hypoxia to calcium signaling in O2-sensing cells? J Biol Chem. 2005; 280(50): 41504-11. PMID: 16199527
24. Bair AM, Thippegowda PB, Freichel M, Cheng N, Ye RD, Vogel SM, et al. Ca2+ entry via TRPC channels is necessary for thrombin-induced NF-kappaB activation in endothelial cells through AMP-Activated protein kinase and protein kinase Cdelta. J BiolChem. 2009; 284(1): 563-74.
25. Zhang F, Dey D, Branstrom R, Forsberg L, Lu M, Zhang Q, et al. BLX-1002, a novel thiazolidinedione with no PPAR affinity, stimulates AMP-Activated protein kinase activity, raises cytosolic Ca2+, and enhances glucose-stimulated insulin secretion in a PI3K-dependent manner. Am J Physiol Cell Physiol. 2009; 296(2): C346-C54. doi:10.1152/ajpcell.00444.2008 PMID: 19052259
26. McGee SL, Hargreaves M. AMPK and transcriptional regulation. Front Biosci. 2008; 13: 3022-33. PMID: 17981775
27. Carling D. The role of the AMP-Activated protein kinase in the regulation of energy homeostasis. NovartisFoundSymp. 2007; 286: 72-81.
28. Winder WW, Holmes BF, Rubink DS, Jensen EB, Chen M, Holloszy JO. Activation of AMP-Activated protein kinase increases mitochondrial enzymes in skeletal muscle. J Appl Physiol. 2000; 88(6): 2219-26. PMID: 10846039
29. Horman S, Beauloye C, Vanoverschelde JL, Bertrand L. AMP-Activated protein kinase in the control of cardiac metabolism and remodeling. Curr Heart Fail Rep. 2012; 9(3): 164-73. doi:10.1007/s11897-012-0102-z PMID: 22767403.
30. Foller M, Sopjani M, Koka S, Gu S, Mahmud H, Wang K, et al. Regulation of erythrocyte survival by AMP-Activated protein kinase. FASEB J. 2009; 23(4): 1072-80. doi:10.1096/fj.08-121772 PMID: 19050047
31. Hardie DG. The AMP-Activated protein kinase pathway-new players upstream and downstream. J Cell Sci. 2004; 117(Pt 23): 5479-87. PMID: 15509864
32. Lokmic Z, Musyoka J, Hewitson TD, Darby IA. Hypoxia and hypoxia signaling in tissue repair and fibrosis. Int Rev Cell Mol Biol. 2012; 296: 139-85. doi:10.1016/B978-0-12-394307-1.00003-5 PMID: 22559939.
33. Lee JH, Kim JH, Kim JS, Chang JW, Kim SB, Park JS, et al. AMP-Activated protein kinase inhibits TGFbeta-, angiotensin II-, aldosterone-, high glucose-, and albumin-induced epithelial-mesenchymal transition. Am J Physiol Renal Physiol. 2013; 304(6): F686-97. doi:10.1152/ajprenal.00148.2012 PMID: 23324179.
34. Chen KH, Hsu HH, Lee CC, Yen TH, Ko YC, Yang CW, et al. The AMPK Agonist AICAR Inhibits TGFbeta1 Induced Activation of Kidney Myofibroblasts. PLoS One. 2014; 9(9): e106554. doi:10.1371/journal.pone.0106554 PMID: 25188319; PubMed Central PMCID: PMC4154690.
35. Mishra R, Cool BL, Laderoute KR, Foretz M, Viollet B, Simonson MS. AMP-Activated protein kinase inhibits transforming growth factor-beta-induced Smad3-dependent transcription and myofibroblast transdifferentiation. J Biol Chem. 2008; 283(16): 10461-9. doi:10.1074/jbc.M800902200 PMID: 18250161.
36. Bascands JL, Schanstra JP. Obstructive nephropathy: insights from genetically engineered animals. Kidney Int. 2005; 68(3): 925-37. doi:10.1111/j.1523-1755.2005.00486.x PMID: 16105023; PubMed Central PMCID: PMC1885837.
37. Samarakoon R, Overstreet JM, Higgins SP, Higgins PJ. TGF-beta1-> SMAD/p53/USF2-> PAI-1 transcriptional axis in ureteral obstruction-induced renal fibrosis. Cell Tissue Res. 2012; 347(1): 117-28. doi:10.1007/s00441-011-1181-y PMID: 21638209; PubMed Central PMCID: PMC3188682.
38. Jorgensen SB, Viollet B, Andreelli F, Frosig C, Birk JB, Schjerling P, et al. Knockout of the alpha2 but not alpha1 5'-AMP-Activated protein kinase isoform abolishes 5-Aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle. J Biol Chem. 2004; 279(2): 1070-9. doi:10.1074/jbc.M306205200 PMID: 14573616.
39. Xiong M, Gong J, Liu Y, Xiang R, Tan X. Loss of vitamin D receptor in chronic kidney disease: a potential mechanism linking inflammation to epithelial-To-mesenchymal transition. Am J Physiol Renal Physiol. 2012; 303(7): F1107-15. doi:10.1152/ajprenal.00151.2012 PMID: 22791341.
40. Voelkl J, Mia S, Meissner A, Ahmed MS, Feger M, Elvira B, et al. PKB/SGK-resistant GSK-3 signaling following unilateral ureteral obstruction. Kidney Blood Press Res. 2013; 38(1): 156-64. doi:10.1159/000355763 PMID: 24685987.
41. Steinberg GR. Role of the AMP-Activated protein kinase in regulating fatty acid metabolism during exercise. Appl Physiol Nutr Metab. 2009; 34(3): 315-22. doi:10.1139/H09-009 PMID: 19448692.
42. Ma FY, Tesch GH, Ozols E, Xie M, Schneider MD, Nikolic-Paterson DJ. TGF-beta1-Activated kinase-1 regulates inflammation and fibrosis in the obstructed kidney. Am J Physiol Renal Physiol. 2011; 300(6): F1410-21. doi:10.1152/ajprenal.00018.2011 PMID: 21367917.
43. Xie M, Zhang D, Dyck JR, Li Y, Zhang H, Morishima M, et al. A pivotal role for endogenous TGF-betaactivated kinase-1 in the LKB1/AMP-Activated protein kinase energy-sensor pathway. Proc Natl Acad Sci U S A. 2006; 103(46): 17378-83. doi:10.1073/pnas.0604708103 PMID: 17085580; PubMed Central PMCID: PMC1859937.
44. Herrero-Martin G, Hoyer-Hansen M, Garcia-Garcia C, Fumarola C, Farkas T, Lopez-Rivas A, et al. TAK1 activates AMPK-dependent cytoprotective autophagy in TRAIL-Treated epithelial cells. EMBO J. 2009; 28(6): 677-85. doi:10.1038/emboj.2009.8 PMID: 19197243; PubMed Central PMCID: PMC2666037.
45. Sasaki Y, Sugamura K. Involvement of Hgs/Hrs in signaling for cytokine-mediated c-fos induction through interaction with TAK1 and Pak1. J Biol Chem. 2001; 276(32): 29943-52. doi:10.1074/jbc. M104230200 PMID: 11397816.
46. Yu Y, Ge N, Xie M, Sun W, Burlingame S, Pass AK, et al. Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop is required for interleukin(IL) -1-mediated optimal NFkappaB and AP-1 activation as well as IL-6 gene expression. J Biol Chem. 2008; 283(36): 24497-505. doi:10.1074/jbc.M802825200 PMID: 18617512; PubMed Central PMCID: PMC2528992.
47. Dai Y, Zhang W, Wen J, Zhang Y, Kellems RE, Xia Y. A2B adenosine receptor-mediated induction of IL-6 promotes CKD. J Am Soc Nephrol. 2011; 22(5): 890-901. doi:10.1681/ASN.2010080890 PMID: 21511827; PubMed Central PMCID: PMC3083311.
48. Silverstein DM, Travis BR, Thornhill BA, Schurr JS, Kolls JK, Leung JC, et al. Altered expression of immune modulator and structural genes in neonatal unilateral ureteral obstruction. Kidney Int. 2003; 64(1): 25-35. doi:10.1046/j.1523-1755.2003.00067.x PMID: 12787392.
49. Cieslik KA, Trial J, Entman ML. Defective myofibroblast formation from mesenchymal stem cells in the aging murine heart rescue by activation of the AMPK pathway. Am J Pathol. 2011; 179(4): 1792-806. doi:10.1016/j.ajpath.2011.06.022 PMID: 21819956; PubMed Central PMCID: PMC3181380.
50. Roca H, Varsos ZS, Sud S, Craig MJ, Ying C, Pienta KJ. CCL2 and interleukin-6 promote survival of human CD11b+ peripheral blood mononuclear cells and induce M2-Type macrophage polarization. J Biol Chem. 2009; 284(49): 34342-54. doi:10.1074/jbc.M109.042671 PMID: 19833726; PubMed Central PMCID: PMC2797202.
51. Chen G, Lin SC, Chen J, He L, Dong F, Xu J, et al. CXCL16 recruits bone marrow-derived fibroblast precursors in renal fibrosis. J Am Soc Nephrol. 2011; 22(10): 1876-86. doi:10.1681/ASN.2010080881 PMID: 21816936; PubMed Central PMCID: PMC3187185.
52. Pan B, Liu G, Jiang Z, Zheng D. Regulation of renal fibrosis by macrophage polarization. Cell Physiol Biochem. 2015; 35(3): 1062-9. doi:10.1159/000373932 PMID: 25662173.
53. Yang J, Lin SC, Chen G, He L, Hu Z, Chan L, et al. Adiponectin promotes monocyte-To-fibroblast transition in renal fibrosis. J Am Soc Nephrol. 2013; 24(10): 1644-59. doi:10.1681/ASN.2013030217 PMID: 23833260; PubMed Central PMCID: PMC3785282.
54. Shen YY, Charlesworth JA, Kelly JJ, Loi KW, Peake PW. Up-regulation of adiponectin, its isoforms and receptors in end-stage kidney disease. Nephrol Dial Transplant. 2007; 22(1): 171-8. doi:10.1093/ndt/gfl552 PMID: 17005524.
55. Noppe G, Dufeys C, Buchlin P, Marquet N, Castanares-Zapatero D, Balteau M, et al. Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKalpha1. J Mol Cell Cardiol. 2014; 74: 32-43. doi:10.1016/j.yjmcc.2014.04.018 PMID: 24805196.
56. Ma Y, Halade GV, Zhang J, Ramirez TA, Levin D, Voorhees A, et al. Matrix metalloproteinase-28 deletion exacerbates cardiac dysfunction and rupture after myocardial infarction in mice by inhibiting M2 macrophage activation. Circ Res. 2013; 112(4): 675-88. doi:10.1161/CIRCRESAHA.111.300502 PMID: 23261783; PubMed Central PMCID: PMC3597388.
57. Hattori Y, Akimoto K, Nishikimi T, Matsuoka H, Kasai K. Activation of AMP-Activated protein kinase enhances angiotensin ii-induced proliferation in cardiac fibroblasts. Hypertension. 2006; 47(2): 265-70. doi:10.1161/01.HYP.0000198425.21604.aa PMID: 16380538.
58. Cieslik KA, Taffet GE, Crawford JR, Trial J, Mejia Osuna P, Entman ML. AICAR-dependent AMPK activation improves scar formation in the aged heart in a murine model of reperfused myocardial infarction. J Mol Cell Cardiol. 2013; 63: 26-36. doi:10.1016/j.yjmcc.2013.07.005 PMID: 23871790; PubMed Central PMCID: PMC3820161.
59. Liu X, Chhipa RR, Pooya S, Wortman M, Yachyshin S, Chow LM, et al. Discrete mechanisms of mTOR and cell cycle regulation by AMPK agonists independent of AMPK. Proc Natl Acad Sci U S A. 2014; 111(4): E435-44. doi:10.1073/pnas.1311121111 PMID: 24474794; PubMed Central PMCID: PMC3910576.
60. Xu X, Lu Z, Fassett J, Zhang P, Hu X, Liu X, et al. Metformin protects against systolic overload-induced heart failure independent of AMP-Activated protein kinase alpha2. Hypertension. 2014; 63(4): 723-8. doi:10.1161/HYPERTENSIONAHA.113.02619 PMID: 24420540; PubMed Central PMCID: PMC4026291.
61. Kim M, Shen M, Ngoy S, Karamanlidis G, Liao R, Tian R. AMPK isoform expression in the normal and failing hearts. J Mol Cell Cardiol. 2012; 52(5): 1066-73. doi:10.1016/j.yjmcc.2012.01.016 PMID: 22314372; PubMed Central PMCID: PMC3327798.
62. Wang S, Zhang M, Liang B, Xu J, Xie Z, Liu C, et al. AMPKalpha2 deletion causes aberrant expression and activation of NAD(P) H oxidase and consequent endothelial dysfunction in vivo: role of 26S proteasomes. Circ Res. 2010; 106(6): 1117-28. doi:10.1161/CIRCRESAHA.109.212530 PMID: 20167927; PubMed Central PMCID: PMC2920052.
63. Liang Y, Huang B, Song E, Bai B, Wang Y. Constitutive activation of AMPK alpha1 in vascular endothelium promotes high-fat diet-induced fatty liver injury: role of COX-2 induction. Br J Pharmacol. 2014; 171(2): 498-508. doi:10.1111/bph.12482 PMID: 24372551; PubMed Central PMCID: PMC3904267.